Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The novel SLAM family member pseudogene (ENSG00000229961, also known as AL357143.1) is annotated in the human genome as a pseudogene related to the SLAM family of immunoreceptors. SLAM family members are type I transmembrane receptors involved in immune cell signaling and regulation, but this pseudogene does not encode a functional protein and does not participate in canonical SLAM/RNA/protein functions. As a pseudogene, it arose from gene duplication and subsequent loss of function through mutation, and is not relevant as a protein-coding target for pharmacological or biomarker purposes. The entry may be confusing due to the presence of functional SLAM family members as important immune regulators, but the "novel SLAM family member pseudogene" itself is not an active receptor or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel SLAM family member pseudogene.